Search for: "Gilead Sciences Inc."
Results 41 - 60
of 182
Sort by Relevance
|
Sort by Date
23 Oct 2020, 12:42 pm
Gilead Sciences Inc. 20-380Issues: (1) Whether, as the U.S. [read post]
5 Oct 2020, 2:00 am
Settle in with the Chat Français for some French carb loading of delicious, fresh patent decisions from the first half of 2020Finding it difficult to keep up with an ever-changing world in the midst of a health, environmental, social and political crisis, while keeping up with patent law? [read post]
24 Sep 2020, 7:39 am
According to DOJ’s press release: Pharmaceutical company Gilead Sciences, Inc. [read post]
23 Jun 2020, 11:30 am
Just this spring, Gilead Sciences, Inc., of Foster City, Ca., bought a firm backed directly and indirectly by CIRM with $45 million. [read post]
12 May 2020, 4:00 am
Gilead Sciences Canada, Inc., 2020 FC 486, another decision decided by Justice Manson, the defendant sought summary trial on the meaning of a key term of the asserted patent claims and non-infringement. [read post]
3 May 2020, 2:25 pm
Gilead Sciences Inc. [read post]
21 Apr 2020, 2:01 am
In Gilead Sciences, Inc. v. [read post]
12 Apr 2020, 6:03 am
As the Financial Times reported, Gilead Sciences renounced an orphan drug designation in the US that granted special status to its potential coronavirus treatment remdesivir. [read post]
10 Mar 2020, 6:48 am
"The piece pulled together the events of last week involving the purchase of Forty Seven, Inc., a grantee of the stem cell agency, by Gilead Sciences, Inc., for $4.9 billion. [read post]
8 Mar 2020, 7:53 pm
Or Gilead Sciences, Inc., the new owner of Forty Seven, could convert the CIRM grant to a loan, which then could be paid off with interest, ending the possibility of extended royalties from the company. [read post]
6 Mar 2020, 3:23 pm
Gilead Sciences, Inc., of Foster City, Ca., announced Monday that it is buying Forty Seven for $4.9 billion which amounts to a price of $95.50 a share. [read post]
3 Mar 2020, 3:45 pm
If you missed it, the deal involves the $4.9 billion purchase of Forty Seven, Inc., by Gilead Sciences, Inc., two companies nestled only 20 minutes apart on the San Francisco Bay peninsula. [read post]
'Perfect Example' and 'Broader Utility:' Pieces of the Forty Seven-Gilead-California Stem Cell Story
2 Mar 2020, 3:34 pm
It came as Gilead Sciences, Inc., and Forty Seven announced this morning that the firm would be purchased by Gilead for $4.9 billion. [read post]
2 Mar 2020, 8:01 am
Gilead Sciences, Inc., of Foster City, Ca., is purchasing Forty Seven for $95.50 a share. [read post]
1 Mar 2020, 7:47 pm
Gilead Sciences Inc. et al., 2017 WL 1015621, at *2 (Del. [read post]
28 Feb 2020, 3:27 pm
The stock took off this morning on the basis of news reports that Gilead Sciences, Inc., was in talks with the company about a possible purchase. [read post]
28 Feb 2020, 7:27 am
The jump occurred as the rest of the market continued its deep slump.The trigger for Forty Seven was a report from Bloomberg News that Gilead Sciences, Inc., had approached the Menlo Park, Ca., company with a takeover bid.This morning's stock price of $60,34, however, was still below the company's 52-week high of $65. [read post]
6 Jan 2020, 6:00 pm
The tech companies seeking to keep their diversity reports secret are Oracle America Inc., Box Inc., Fitbit Inc., Applied Materials Inc., Equinix Inc., Gilead Sciences Inc., Synopsys Inc., DocuSign Inc., Agilent Technologies Inc. and Xilinx Inc…” [read post]
2 Jan 2020, 9:25 am
Data examined by healthcare research firm 3 Axis Advisors found that major drug makers including Pfizer Inc, GlaxoSmithKline PLC, and Sanofi SA, Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked prices this week. [read post]
1 Jan 2020, 11:35 am
Truvada tablets Author Jeffrey Beall Licence CC BY-SA 3.0 Source Wikipedia Emtricitabine/tenofovir Jane Lambert Court of Appeal (Lord Justices Lewison, Floyd and Dingemans) Teva UK Ltd and others v Gilead Sciences, Inc [2019] EWCA Civ 2272 (19 Dec2019) This was an appeal against Mr Justice Arnold's decision in Teva UK Ltd and others v Gilead Sciences Inc [2018] EWHC 2416 [read post]
